magent
Deterministic published-formula arithmetic plus ICD-10-CM, RxNorm, and LOINC. Pay in USDC on Base via x402.
Otherofflineeip155:8453Exactvia cdp
MrecistHccLiverResponseCalculator
Calls · 30d
1→ 0%
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 8 snapshots so far.
$13.75
Verified settled volume
2,750 settlements proven x402 by their on-chain EIP-3009 marker.
$0.0050
Listed price
As published in the catalog. Always read the live 402 before paying.
1
Calls · 30d
Upstream's own call count for this endpoint, not ours.
1
Unique payers · 30d
Last called 2026-09-02 02:17Z
—
Upstream on-chain volume
Reported by the source catalog.
Paid to
0x836Be278f1739fB4308091cD1852F7971Bc19Ee2The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.
Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913
Provider
The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.
Live 402 challenge
Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.
{
"error": "PAYMENT-SIGNATURE header is required",
"accepts": [
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/mrecist",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
},
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"withdrawDelay": 86400,
"receiverAuthorizer": "0x3721824a31197dcDD2984cF43b92B6cc8A87c0Fb",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "batch-settlement",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
],
"resource": {
"url": "https://api.magentlab.com/api/calc/mrecist",
"tags": [
"mrecist",
"hcc",
"liver",
"response",
"calculator"
],
"mimeType": "application/json",
"description": "Lencioni 2010 mRECIST for typical intrahepatic HCC target lesions. First-match: PD if new_lesion or a 20% or greater viable-sum increase vs nadir; else CR if arterial enhancement disappeared in all targets; else PR if a 30% or greater viable-sum decrease vs baseline; else SD. Caller-assigned flags; magent does not read imaging. Not a medical device, not a diagnosis, not RECIST 1.1, not EASL necrosis-only, not the 2019 Llovet +5 mm PD refinement, and not nontarget-only overall response.",
"serviceName": "magent"
},
"extensions": {
"bazaar": {
"info": {
"input": {
"type": "http",
"method": "GET",
"queryParams": {
"new_lesion": false,
"enhancement_disappeared": true,
"viable_sum_increase_ge_20": false,
"viable_sum_reduction_ge_30": false
}
},
"output": {
"type": "json",
"example": {
"formula": "mrecist",
"mrecist": "CR",
"citation": {
"id": "lencioni-2010",
"doi": "10.1055/s-0030-1247132",
"pmid": "20175033",
"title": "Modified RECIST (mRECIST) assessment for hepatocellular carcinoma",
"source": "Semin Liver Dis. 2010;30(1):52-60",
"authors": "Lencioni R, Llovet JM"
},
"criteria": [
{
"met": false,
"factor": "new_lesion"
},
{
"met": false,
"factor": "viable_sum_increase_ge_20"
},
{
"met": true,
"factor": "enhancement_disappeared"
},
{
"met": false,
"factor": "viable_sum_reduction_ge_30"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula_expression": "mrecist first-match: PD if new_lesion or viable_sum_increase_ge_20; else CR if enhancement_disappeared; else PR if viable_sum_reduction_ge_30; else SD (Lencioni 2010 typical intrahepatic target lesions). Not RECIST 1.1. Not EASL necrosis-only. Not the 2019 Llovet +5 mm PD refinement. magent does not read imaging. Not a diagnosis"
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"type": {
"type": "string",
"const": "http"
},
"method": {
"enum": [
"GET",
"HEAD",
"DELETE"
],
"type": "string"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
},
"queryParams": {
"type": "object",
"required": [
"new_lesion",
"viable_sum_increase_ge_20",
"enhancement_disappeared",
"viable_sum_reduction_ge_30"
],
"properties": {
"new_lesion": {
"type": "boolean",
"description": "One or more new lesions as assigned by the caller (Lencioni 2010 mRECIST PD). true or false. When true, mrecist is PD regardless of enhancement or viable-sum flags. magent does not read imaging."
},
"enhancement_disappeared": {
"type": "boolean",
"description": "Disappearance of any intratumoral arterial enhancement in all target lesions, as assigned by the caller (Lencioni 2010 mRECIST CR). true or false. magent does not measure arterial-phase enhancement or read CT/MRI."
},
"viable_sum_increase_ge_20": {
"type": "boolean",
"description": "≥20% increase in the sum of diameters of viable (arterial-enhancing) target lesions versus nadir, as assigned by the caller (Lencioni 2010 mRECIST PD). Do not also require a 5 mm absolute increase. true or false. magent does not measure lesions."
},
"viable_sum_reduction_ge_30": {
"type": "boolean",
"description": "≥30% decrease in the sum of diameters of viable (arterial-enhancing) target lesions versus baseline, as assigned by the caller (Lencioni 2010 mRECIST PR). true or false. magent does not measure lesions."
}
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
},
"x402Version": 2
}Accepts
The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.
0.005USDC≈ $0.005 USD
on Base · exact scheme
Pay 0.005 USDC on Base to 0x836B…19Ee2. The signed payment is good for 10 minutes.
- Paid to
- 0x836B…19Ee2
- USD Coin contract
- 0x8335…02913
- Payment window
- 10 minutes
- As published
- 5000 smallest units
The catalog’s raw entry
[
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/mrecist",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
]Extensions
{
"bazaar": {
"info": {
"input": {
"body": {
"items": [
{
"new_lesion": false,
"enhancement_disappeared": true,
"viable_sum_increase_ge_20": false,
"viable_sum_reduction_ge_30": false
},
{
"new_lesion": false,
"enhancement_disappeared": true,
"viable_sum_increase_ge_20": false,
"viable_sum_reduction_ge_30": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/mrecist",
"count": 2,
"items": [
{
"formula": "mrecist",
"mrecist": "CR",
"citation": {
"id": "lencioni-2010",
"doi": "10.1055/s-0030-1247132",
"pmid": "20175033",
"title": "Modified RECIST (mRECIST) assessment for hepatocellular carcinoma",
"source": "Semin Liver Dis. 2010;30(1):52-60",
"authors": "Lencioni R, Llovet JM"
},
"criteria": [
{
"met": false,
"factor": "new_lesion"
},
{
"met": false,
"factor": "viable_sum_increase_ge_20"
},
{
"met": true,
"factor": "enhancement_disappeared"
},
{
"met": false,
"factor": "viable_sum_reduction_ge_30"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula_expression": "mrecist first-match: PD if new_lesion or viable_sum_increase_ge_20; else CR if enhancement_disappeared; else PR if viable_sum_reduction_ge_30; else SD (Lencioni 2010 typical intrahepatic target lesions). Not RECIST 1.1. Not EASL necrosis-only. Not the 2019 Llovet +5 mm PD refinement. magent does not read imaging. Not a diagnosis"
},
{
"formula": "mrecist",
"mrecist": "CR",
"citation": {
"id": "lencioni-2010",
"doi": "10.1055/s-0030-1247132",
"pmid": "20175033",
"title": "Modified RECIST (mRECIST) assessment for hepatocellular carcinoma",
"source": "Semin Liver Dis. 2010;30(1):52-60",
"authors": "Lencioni R, Llovet JM"
},
"criteria": [
{
"met": false,
"factor": "new_lesion"
},
{
"met": false,
"factor": "viable_sum_increase_ge_20"
},
{
"met": true,
"factor": "enhancement_disappeared"
},
{
"met": false,
"factor": "viable_sum_reduction_ge_30"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula_expression": "mrecist first-match: PD if new_lesion or viable_sum_increase_ge_20; else CR if enhancement_disappeared; else PR if viable_sum_reduction_ge_30; else SD (Lencioni 2010 typical intrahepatic target lesions). Not RECIST 1.1. Not EASL necrosis-only. Not the 2019 Llovet +5 mm PD refinement. magent does not read imaging. Not a diagnosis"
}
]
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"body": {
"type": "object",
"required": [
"items"
],
"properties": {
"items": {
"type": "array",
"items": {
"type": "object",
"required": [
"new_lesion",
"viable_sum_increase_ge_20",
"enhancement_disappeared",
"viable_sum_reduction_ge_30"
],
"properties": {
"new_lesion": {
"type": "boolean",
"description": "One or more new lesions as assigned by the caller (Lencioni 2010 mRECIST PD). true or false. When true, mrecist is PD regardless of enhancement or viable-sum flags. magent does not read imaging."
},
"enhancement_disappeared": {
"type": "boolean",
"description": "Disappearance of any intratumoral arterial enhancement in all target lesions, as assigned by the caller (Lencioni 2010 mRECIST CR). true or false. magent does not measure arterial-phase enhancement or read CT/MRI."
},
"viable_sum_increase_ge_20": {
"type": "boolean",
"description": "≥20% increase in the sum of diameters of viable (arterial-enhancing) target lesions versus nadir, as assigned by the caller (Lencioni 2010 mRECIST PD). Do not also require a 5 mm absolute increase. true or false. magent does not measure lesions."
},
"viable_sum_reduction_ge_30": {
"type": "boolean",
"description": "≥30% decrease in the sum of diameters of viable (arterial-enhancing) target lesions versus baseline, as assigned by the caller (Lencioni 2010 mRECIST PR). true or false. magent does not measure lesions."
}
}
},
"maxItems": 25,
"minItems": 1
}
},
"additionalProperties": false
},
"type": {
"type": "string",
"const": "http"
},
"method": {
"type": "string",
"const": "POST"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
}Provenance
- Seen in the source catalog
- 2026-09-02 02:17Z
- Last indexed by Roundhouse
- 2026-09-07 06:20Z
- Last enriched (probe, favicon, geo)
- 2026-09-10 17:45Z
- x402 version
- 2
- Max timeout
- 600s
- Liveness probe
- HTTP 0
Hand this page to an agent
Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.
GET api.roundhouseai.io/v0/endpoints
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 8 snapshots so far. Verified volume counts only settlements with an on-chain EIP-3009 marker.
Show the promptHide the prompt
Using Roundhouse, look up the x402 service magent and tell me whether it is worth paying: what a call costs, whether the endpoint answered when last probed, and what its payment record actually shows. curl -s 'https://api.roundhouseai.io/v0/endpoints?q=magent' curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>' Then call it: read the price from the live 402 at https://api.magentlab.com/api/calc/mrecist, never from a cached figure, and pay with an x402 client. The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except /v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402, or use an organization key from https://roundhouseai.io/dashboard/team. If you do not have Roundhouse tools or skills installed, read https://roundhouseai.io/skill.md first — it is the whole procedure.